Rabia Gurses Ozden Ocular Therapeutix, Inc (OCUL) insider trading activity

Rabia Gurses Ozden is Chief Medical Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 153,054 shares of OCUL, which is worth approximately $1.59 Million. The most recent transaction as insider was on Feb 05, 2024, when has been sold 6,346 shares (Common Stock) at a price of $4.86 per share, resulting in proceeds of $30,841. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

0% 3M change

52.25% 12M change

Total Value Held $1.59 Million

Rabia Gurses Ozden Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2024	BUY Open market or private sale	$30,841 $4.86 p/Share	6,346 Added 3.98%	153,054 Common Stock
Feb 03 2024	BUY Grant, award, or other acquisition	-	66,633 Added 29.48%	159,400 Common Stock
Jan 31 2024	SELL Open market or private sale	$38,431 $4.95 p/Share	7,764 Reduced 7.72%	92,767 Common Stock
Jul 07 2023	SELL Open market or private sale	$4,101 $4.93 p/Share	832 Reduced 0.82%	100,531 Common Stock
Feb 06 2023	SELL Open market or private sale	$27,203 $4.24 p/Share	6,416 Reduced 5.95%	101,363 Common Stock
Jan 30 2023	BUY Grant, award, or other acquisition	-	55,556 Added 34.01%	107,779 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	6,667 Added 11.32%	52,223 Common Stock

Also insider at

ADVM

Adverum Biotechnologies, Inc. Healthcare

Chief Medical Officer

RGO